• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA IDL SET Back to Search Results
Catalog Number 10310
Device Problem Clumping in Device or Device Ingredient (1095)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/24/2016
Event Type  Injury  
Manufacturer Narrative
Investigation: per the customer, no clotting was noted during the procedure anywhere in the set.When the operator started rinse back, he began to see clumping in the collection bag and agitated the bag.He did not see any clumping in the collect line going to the collection bag.He finished rinse back to the patient without any problems.The collected product appeared to be clotted to him and another colleague when he was preparing the bag for transport to the lab.Per the customer, 12.2mls of acda was added to the collection bag prior to the start of the procedure.The customer stated that they set the anticoagulant (ac) ratio of 12:1 for a platelet count of 292.Per the customer, the clotting could have not been returned to the patient because the collect valve was closed to the collection bag and the operator did not see any clots in the collect line leading to the collection bag.Complete blood count (cbc) testing was performed and product cultures taken with negative test results.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that following a continuous mononuclear cell (cmnc) collection procedure, clotting was noted in the collection bag.Rinse back was completed successfully at the end of the procedure and there were no patient problems.No viable product was collected.This was an allogeneic donor.The recipient patient had already been prepared for transplant, so the donor had to come back in for a bone marrow aspiration and was hospitalized.The patient (donor) is reported in healthy condition.Terumo bct is awaiting return of the disposable set for evaluation.
 
Manufacturer Narrative
Investigation: the run data file (rdf) was analyzed for this event.Signals in the rdf indicated that the spectra optia system operated as intended.The interface images indicated that there was some minor clumping present in the collect port throughout the collection, but the inlet/ac ratio remained at 12 for the entire collection.The signals in the run data file (rdf) also confirmed that the ac fluid detector was functioning as intended and appropriately identifying fluid and air throughout the procedure.The disposable set was returned for investigation.Upon visual inspection, there was no indication of any occlusions of the ac line that could have resulted in any under delivery of ac to the circuit.Investigation is in progress.A follow-up report will be provided.
 
Manufacturer Narrative
Investigation: the machine involved in this event was evaluated.An autotest and simulated patient run were conducted.The technician was unable to duplicate the reported condition.Investigation is in progress.A follow-up report will be provided.
 
Manufacturer Narrative
Investigation: the device history record (dhr) was reviewed for this lot.There were no issues noted in the dhr that would have contributed to the product clotting as experienced by the customer.Root cause: the signals in the run data file and the investigation of the returned disposable set do not indicate a clear root cause for the clotting observed in the product bag at the end of the procedure.Based on the information available the spectra optia system operated as intended.Possible causes for the clotting include but are not limited to donor physiology and/or inadequate ac ratio for the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA IDL SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
matthew bickford
10810 w. collins ave
lakewood, CO 80215
3032052494
MDR Report Key5582342
MDR Text Key42853326
Report Number1722028-2016-00250
Device Sequence Number1
Product Code LKN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BK151368
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 04/15/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/01/2018
Device Catalogue Number10310
Device Lot Number01Z3227
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/24/2016
Initial Date FDA Received04/15/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Supplement Dates FDA Received05/10/2016
06/03/2016
06/15/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/27/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
Patient Age28 YR
Patient Weight152
-
-